Novavax Inc. NVAX reported positive results from three vaccine trials on Tuesday, one targeting both COVID and flu, one for stand-alone flu and one a high-dose COVID vaccine.…
Read more Novavax reports positive results in trial of 3 vaccines for flu and COVID, posts Q1 loss and plan to cut 25% of workforceWhile many have been focused on the apparent explosion of COVID cases in China, and the lack of reliable data from China’s government, there are signs suggesting the…
Read more COVID-related ICU patients rise to 5-month high above 5,000—are new cases really falling?Novavax Inc. Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola,…
Read more NVAX Stock Price | Novavax Inc. Stock Quote (U.S.: Nasdaq) | MarketWatchThe White House has unveiled a fresh push to increase COVID preparedness heading into the holidays and will again make free tests available to Americans, after a three-month…
Read more White House preps fresh push to urge COVID preparedness ahead of holidays, including free tests for all householdsThe head of the International Monetary Fund on Tuesday joined the chorus of people urging China to adopt a more targeted approach to the coronavirus pandemic as the…
Read more IMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderlyA fresh analysis of data on the immune response generated by the bivalent COVID-19 booster showed strong results against the newer omicron sublineages, Pfizer and German partner BioNTech…
Read more Pfizer and BioNTech updated booster shows strong results against new omicron sublineages in fresh analysis of dataShares of Novavax Inc. NVAX, -3.17% were up 2.4% in premarket trading on Friday after the company said its COVID-19 booster was authorized for adults in Canada who…
Read more Novavax’s COVID-19 booster authorized in CanadaThe southern Chinese manufacturing hub of Guangzhou is the latest to see lockdowns amid a surge in COVID-19 cases, as the government presses ahead with the strict zero-COVID…
Read more Manufacturing hub Guangzhou is latest Chinese city to face lockdowns as COVID cases riseThe Centers for Disease Control and Prevention has refuted claims that it’s planning to add the COVID-19 vaccine to immunization schedules for schoolchildren, saying that the authority for…
Read more CDC shoots down false claims it will mandate COVID-19 vaccines for schoolchildren, saying states make that decisionPfizer Inc. PFE, +4.17% said Thursday that it plans to sell the COVID-19 shot it developed with BioNTech SE BNTX, +7.14% for $110 to $130 per dose once…
Read more Pfizer sets new prices for its COVID-19 vaccines. The cost? $110 to $130 per dose
